Neurocrine Biosciences Inc (NASDAQ:NBIX)

42.94
Delayed Data
As of May 27
 +0.64 / +1.51%
Today’s Change
12.63
Today|||52-Week Range
45.36
+92.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.7B

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders8.90%
Mutual fund holders65.79%
Other institutional37.32%

Top Executives

Kevin Charles GormanPresident, Chief Executive Officer & Director
Bill WilsonVice President-Information Technology & Operations
Timothy P. CoughlinChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Christopher Flint O'BrienChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account